enGene Therapeutics, Inc. (ENGN)
1.64
-0.09
(-5.20%)
USD |
NASDAQ |
May 22, 16:00
1.73
+0.09
(+5.49%)
Pre-Market: 20:00
enGene Therapeutics Total Assets (Quarterly) : 337.11M for Jan. 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 33.10M |
| Aurinia Pharmaceuticals, Inc. | 724.00M |
| Edesa Biotech, Inc. | 12.38M |
| Xenon Pharmaceuticals, Inc. | 1.387B |
| ProMIS Neurosciences, Inc. | 67.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.57M |
| Shareholders Equity (Quarterly) | 281.55M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 11.75 |
| Net Debt Paydown Yield | -0.26% |